Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Lechner, Christian J ^a   Grüner, Beate ^b   Huang, Xiangsheng ^a   Hoffmann, Wolfgang H ^a   Kern, Peter ^b   Soboslay, Peter T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ECHINOCOCCUS MULTILOCULARIS ANTIGEN 1; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 17 RECEPTOR B; INTERLEUKIN 17B; INTERLEUKIN 17F; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHINOCOCCUS MULTILOCULARIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG HYDATID CYST; MAJOR CLINICAL STUDY; MALE; METACESTODE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; ECHINOCOCCOSIS; IMMUNOLOGY; INFLAMMATION; LIVER HYDATID CYST; LYMPHOCYTE ACTIVATION; MIDDLE AGED; TH17 CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS MULTILOCULARIS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-17; TH17 CELLS; YOUNG ADULT;

EID: 84867028284     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/735342     Document Type: Article

References (46)

1. Piarroux M., Piarroux R., Giorgi R., Knapp J., Bardonnet K., Sudre B., Watelet J., Dumortier J., Gérard A., Beytout J., Abergel A., Mantion G., Vuitton D. A., Bresson-Hadni S., Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: results of a survey in 387 patients. Journal of Hepatology 2011 55 5 1025 1033 2-s2.0-79960662713 10.1016/j.jhep.2011.02.018
2. Kern P., Clinical features and treatment of alveolar echinococcosis. Current Opinion in Infectious Diseases 2010 23 5 505 512 2-s2.0-77956228087 10.1097/QCO.0b013e32833d7516
3. Gottstein B., Felleisen R., Protective immune mechanisms against the metacestode of Echinococcus multilocularis. Parasitology Today 1995 11 9 320 326 2-s2.0-0029147898 10.1016/0169-4758(95)80184-7
4. Vuitton D. A., The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Tropica 2003 85 2 119 132 2-s2.0-0037328435 10.1016/S0001-706X(02)00230-9 (Pubitemid 36246632)
5. Sturm D., Menzel J., Gottstein B., Kern P., Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infection and Immunity 1995 63 5 1688 1697 2-s2.0-0028918196
6. Wellinghausen N., Gebert P., Kern P., Interleukin (IL)-4, IL-10 and IL-12 profile in serum of patients with alveolar echinococcosis. Acta Tropica 1999 73 2 165 174 2-s2.0-0032804985 10.1016/S0001-706X(99)00027-3 (Pubitemid 29341604)
7. Jenne L., Kilwinski J., Scheffold W., Kern P., IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis -infected patients. Clinical and Experimental Immunology 1997 109 1 90 97 2-s2.0-0030740631 (Pubitemid 27293889)
8. Godot V., Harraga S., Deschaseaux M., Bresson-Hadni S., Gottstein B., Emilie D., Vuitton D. A., Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis. European Cytokine Network 1997 8 4 401 408 2-s2.0-0031449847 (Pubitemid 28031329)
9. Schmid M., Samonigg H., Stöger H., Auer H., Sternthal M. H., Wilders-Truschnig M., Reisinger E. C., Use of interferon γ and mebendazole to stop the progression of alveolar hydatid disease: case report. Clinical Infectious Diseases 1995 20 6 1543 1546 2-s2.0-0029015743
10. Hübner M. P., Manfras B. J., Margos M. C., Eiffler D., Hoffmann W. H., Schulz-Key H., Kern P., Soboslay P. T., Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clinical and Experimental Immunology 2006 145 2 243 251 2-s2.0-33745946674 10.1111/j.1365-2249.2006.03142.x (Pubitemid 44060114)
11. Emery I., Leclerc C., Sengphommachanh K., Vuitton D. A., Liance M., In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunology 1998 20 2 81 91 2-s2.0-0031970138 10.1046/j.1365-3024.1998.00131.x (Pubitemid 28179128)
12. Liance M., Ricard-Blum S., Emery I., Houin R., Vuitton D. A., Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN- γ decreases metacestode growth and liver fibrogenesis. Parasite 1998 5 3 231 237 2-s2.0-0032158603 (Pubitemid 128505039)
13. Jenne L., Kilwinski J., Radloff P., Flick W., Kern P., Clinical efficacy of and immunologic alterations caused by interferon γ therapy for alveolar echinococcosis. Clinical Infectious Diseases 1998 26 2 492 494 2-s2.0-0031882326 (Pubitemid 28083968)
14. Kocherscheidt L., Flakowski A. K., Grüner B., Hamm D. M., Dietz K., Kern P., Soboslay P. T., Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Experimental Parasitology 2008 119 4 467 474 2-s2.0-46749124615 10.1016/j.exppara.2008.04.006
15. Harraga S., Godot V., Bresson-Hadni S., Mantion G., Vuitton D. A., Profile of cytokine production within the periparasitic granuloma in human alveolar echinococcosis. Acta Tropica 2003 85 2 231 236 2-s2.0-0037327245 10.1016/S0001-706X(02)00218-8 (Pubitemid 36246644)
16. Iwakura Y., Ishigame H., Saijo S., Nakae S., Functional specialization of interleukin-17 family members. Immunity 2011 34 2 149 162 2-s2.0-79951743212 10.1016/j.immuni.2011.02.012
17. Hwang S. Y., Kim J. Y., Kim K. W., Park M. K., Moon Y., Kim W. U., Kim H. Y., IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Research & Therapy 2004 6 2 R120 R128 2-s2.0-5644289875
18. Seiderer J., Elben I., Diegelmann J., Glas J., Stallhofer J., Tillack C., Pfennig S., Jürgens M., Schmechel S., Konrad A., Göke B., Ochsenkühn T., Müller-Myhsok B., Lohse P., Brand S., Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflammatory Bowel Diseases 2008 14 4 437 445 2-s2.0-42449084096 10.1002/ibd.20339 (Pubitemid 351571823)
19. Noda K., Kodama S., Umemoto S., Nomi N., Hirano T., Suzuki M., Th17 cells contribute to nontypeable Haemophilus influenzae -specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α -galactosylceramide. Microbiology and Immunology 2011 55 8 574 581 2-s2.0-79960857044 10.1111/j.1348-0421.2011.00352.x
20. Hanna S., Etzoni A., New host defense mechanisms against Candida species clarify the basis of clinical phenotypes. Journal of Allergy and Clinical Immunology 2011 127 6 1433 1437 2-s2.0-79957868053 10.1016/j.jaci.2011.03.026
21. Kern P., Wen H., Sato N., Vuitton D. A., Gruener B., Shao Y., Delabrousse E., Kratzer W., Bresson-Hadni S., WHO classification of alveolar echinococcosis: principles and application. Parasitology International 2006 55 S283 S287 2-s2.0-32044469863 10.1016/j.parint.2005.11.041 (Pubitemid 43191989)
22. Tappe D., Frosch M., Sako Y., Itoh S., Grüner B., Reuter S., Nakao M., Ito A., Kern P., Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages. American Journal of Tropical Medicine and Hygiene 2009 80 5 792 797 2-s2.0-66149101631
23. Tappe D., Sako Y., Itoh S., Frosch M., Grüner B., Kern P., Ito A., Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages. Clinical and Vaccine Immunology 2010 17 6 944 948 2-s2.0-77953160097 10.1128/CVI.00026-10
24. Eger A., Kirch A., Manfras B., Kern P., Schulz-Key H., Soboslay P. T., Pro-inflammatory (IL-1 β IL-18) cytokines and IL-8 chemokine release by PBMC in response to Echinococcus multilocularis metacestode vesicles. Parasite Immunology 2003 25 2 103 105 2-s2.0-0038539227 10.1046/j.1365-3024.2003.00601.x (Pubitemid 36745646)
25. Conti H. R., Shen F., Nayyar N., Stocum E., Sun J. N., Lindemann M. J., Ho A. W., Hai J. H., Yu J. J., Jung J. W., Filler S. G., Masso-Welch P., Edgerton M., Gaffen S. L., Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. Journal of Experimental Medicine 2009 206 2 299 311 2-s2.0-63049138176 10.1084/jem.20081463
26. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A., Kotaki H., Sudo K., Nakae S., Sasakawa C., Iwakura Y., Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009 30 1 108 119 2-s2.0-58149231532 10.1016/j.immuni.2008.11.009
27. Gaffen S. L., Structure and signalling in the IL-17 receptor family. Nature Reviews Immunology 2009 9 8 556 567 2-s2.0-68849084891 10.1038/nri2586
28. Veldhoen M., Hocking R. J., Atkins C. J., Locksley R. M., Stockinger B., TGF β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006 24 2 179 189 2-s2.0-32244442562 10.1016/j.immuni.2006.01.001 (Pubitemid 43214587)
29. Zhou L., Ivanov I. I., Spolski R., Min R., Shenderov K., Egawa T., Levy D. E., Leonard W. J., Littman D. R., IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 2007 8 9 967 974 2-s2.0-34547188748 10.1038/ni1488 (Pubitemid 47300011)
30. Pappu R., Ramirez-Carrozzi V., Sambandam A., The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 2011 134 1 8 16 2-s2.0-79961210510 10.1111/j.1365-2567.2011.03465.x
31. Walsh K. P., Brady M. T., Finlay C. M., Boon L., Mills K. H. G., Infection with a helminth parasite attenuates autoimmunity through TGF- β -mediated suppression of Th17 and Th1 responses. Journal of Immunology 2009 183 3 1577 1586 2-s2.0-68149125252 10.4049/jimmunol.0803803
32. Tallima H., Salah M., Guirguis F. R., El Ridi R., Transforming growth factor- β and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine 2009 48 3 239 245 2-s2.0-70350007738 10.1016/j.cyto.2009.07.581
33. Mahanty S., Luke H. E., Kumaraswami V., Narayanan P. R., Vijayshekaran V., Nutman T. B., Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Experimental Parasitology 1996 84 2 282 290 2-s2.0-0030297833 10.1006/expr.1996.0114 (Pubitemid 26399794)
34. Viana I. R. C., Sher A., Carvalho O. S., Massara C. L., Eloi-Santos S. M., Pearce E. J., Colley D. G., Gazzinelli G., Correa-Oliveira R., Interferon- γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994 88 4 466 470 2-s2.0-0028168860 10.1016/0035-9203(94)90436-7
35. Li H., Chen J., Huang A., Stinson J., Heldens S., Foster J., Dowd P., Gurney A. L., Wood W. I., Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proceedings of the National Academy of Sciences of the United States of America 2000 97 2 773 778 2-s2.0-0034681131 10.1073/pnas.97.2.773 (Pubitemid 30070385)
36. Kokubu T., Haudenschild D. R., Moseley T. A., Rose L., Reddi A. H., Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing. Journal of Histochemistry and Cytochemistry 2008 56 2 89 95 2-s2.0-38649100002 10.1369/jhc.7A7223.2007 (Pubitemid 351170962)
37. Moore E. E., Presnell S., Garrigues U., Guilbot A., LeGuern E., Smith D., Yao L., Whitmore T. E., Gilbert T., Palmer T. D., Horner P. J., Kuestner R. E., Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease. Neuromuscular Disorders 2002 12 2 141 150 2-s2.0-0036133352 10.1016/S0960-8966(01)00250-4 (Pubitemid 33152732)
38. Shi Y., Ullrich S. J., Zhang J., Connolly K., Grzegorzewski K. J., Barber M. C., Wang W., Wathen K., Hodge V., Fisher C. L., Olsen H., Ruben S. M., Knyazev I., Cho Y. H., Kao V., Wilkinson K. A., Carrell J. A., Ebner R., A novel cytokine receptor-ligand pair: identification, molecular characterization, and in vivo immunomodutory activity. Journal of Biological Chemistry 2000 275 25 19167 19176 2-s2.0-0034705439 10.1074/jbc.M910228199 (Pubitemid 30422887)
39. Yagi Y., Andoh A., Inatomi O., Tsujikawa T., Fujiyama Y., Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. Journal of Gastroenterology 2007 42 9 746 753 2-s2.0-34648846718 10.1007/s00535-007-2091-3 (Pubitemid 47456762)
40. Lee J., Ho W. H., Maruoka M., Corpuz R. T., Baldwin D. T., Foster J. S., Goddard A. D., Yansura D. G., Vandlen R. L., Wood W. I., Gurney A. L., IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. Journal of Biological Chemistry 2001 276 2 1660 1664 2-s2.0-0035846998 10.1074/jbc.M008289200 (Pubitemid 32096603)
41. Yu H. S., Angkasekwinai P., Chang S. H., Chung Y., Dong C., Protease allergens induce the expression of IL-25 via Erk and p38 MAPK pathway. Journal of Korean Medical Science 2010 25 6 829 834 2-s2.0-77956404942 10.3346/jkms.2010.25.6.829
42. Gratchev A., Kzhyshkowska J., Duperrier K., Utikal J., Velten F. W., Goerdt S., The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells. Scandinavian Journal of Immunology 2004 60 3 233 237 2-s2.0-4344586523 10.1111/j.0300-9475.2004.01443.x (Pubitemid 39141253)
43. Aumüller E., Schramm G., Gronow A., Brehm K., Gibbs B. F., Doenhoff M. J., Haas H., Echinococcus multilocularis metacestode extract triggers human basophils to release interleukin-4. Parasite Immunology 2004 26 10 387 395 2-s2.0-14944366225 10.1111/j.0141-9838.2004.00724.x (Pubitemid 40364834)
44. Zhang S., Hüe S., Sène D., Penfornis A., Bresson-Hadni S., Kantelip B., Caillat-Zucman S., Vuitton D. A., Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor- β in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites? Journal of Infectious Diseases 2008 197 9 1341 1349 2-s2.0-43049105344 10.1086/586709 (Pubitemid 351632766)
45. Jung T., Wagner K., Neumann C., Hausser C. H., Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro. European Journal of Immunology 1999 29 3 864 871 2-s2.0-0033024881 (Pubitemid 29119065)
46. Jones S. A., Horiuchi S., Topley N., Yamamoto N., Fuller G. M., The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB Journal 2001 15 1 43 58 2-s2.0-0035164602 10.1096/fj.99-1003rev (Pubitemid 32061655)